Cardlytics Begin Period Cash Flow from 2010 to 2025

CDLX Stock  USD 3.06  0.10  3.16%   
Cardlytics Begin Period Cash Flow yearly trend continues to be fairly stable with very little volatility. Begin Period Cash Flow will likely drop to about 114.4 M in 2025. Begin Period Cash Flow is the amount of cash Cardlytics has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
2016-12-31
Previous Quarter
97.8 M
Current Value
71.2 M
Quarterly Volatility
118.2 M
 
Covid
Check Cardlytics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardlytics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 3.4 M or Depreciation And Amortization of 35.6 M, as well as many indicators such as Price To Sales Ratio of 0.93, Dividend Yield of 0.0 or PTB Ratio of 3.76. Cardlytics financial statements analysis is a perfect complement when working with Cardlytics Valuation or Volatility modules.
  
Check out the analysis of Cardlytics Correlation against competitors.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

Latest Cardlytics' Begin Period Cash Flow Growth Pattern

Below is the plot of the Begin Period Cash Flow of Cardlytics over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. Cardlytics' Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardlytics' overall financial position and show how it may be relating to other accounts over time.
Begin Period Cash Flow10 Years Trend
Slightly volatile
   Begin Period Cash Flow   
       Timeline  

Cardlytics Begin Period Cash Flow Regression Statistics

Arithmetic Mean90,444,401
Geometric Mean67,897,762
Coefficient Of Variation85.34
Mean Deviation58,193,376
Median51,198,000
Standard Deviation77,188,857
Sample Variance5958.1T
Range272.1M
R-Value0.60
Mean Square Error4107.1T
R-Squared0.36
Significance0.01
Slope9,682,145
Total Sum of Squares89371.8T

Cardlytics Begin Period Cash Flow History

2025114.4 M
2024140.3 M
2023122 M
2022233.6 M
2021293.3 M
2020104.6 M
201959.9 M

About Cardlytics Financial Statements

Cardlytics investors use historical fundamental indicators, such as Cardlytics' Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cardlytics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Begin Period Cash Flow140.3 M114.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.